Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$524M |
| 2 |
Meta Platforms (Facebook)
META
|
+$458M |
| 3 |
Otis Worldwide
OTIS
|
+$345M |
| 4 |
T-Mobile US
TMUS
|
+$307M |
| 5 |
AbbVie
ABBV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$878M |
| 2 |
RTN
Raytheon Company
RTN
|
+$537M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$435M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
Accenture
ACN
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.72% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 12.98% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PEI
3126
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $1M | ﹤0.01% |
49,115
-28,491
| -37% | -$514K |
|
3127
Aldeyra Therapeutics
ALDX
$92.9M
| $999K | ﹤0.01% |
239,598
-93,156
| -28% | -$340K |
|
3128
Solid Biosciences
SLDB
$794M
| $994K | ﹤0.01% |
22,638
+2,925
| +15% | +$121K |
|
|
TA
3129
DELISTED
TravelCenters of America LLC
TA
| $986K | ﹤0.01% |
64,076
-1,216
| -2% | -$15.5K |
|
3130
Marker Therapeutics
MRKR
$18.8M
| $979K | ﹤0.01% |
47,334
+3,922
| +9% | +$85.8K |
|
3131
Geospace Technologies
GEOS
$94.6M
| $978K | ﹤0.01% |
130,065
-77,229
| -37% | -$514K |
|
|
VTLE
3132
DELISTED
Vital Energy
VTLE
| $978K | ﹤0.01% |
70,598
-59,169
| -46% | -$925K |
|
3133
Exagen
XGN
$109M
| $978K | ﹤0.01% |
78,878
+13,377
| +20% | +$181K |
|
|
ARCE
3134
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
| $978K | ﹤0.01% |
22,512
+3,251
| +17% | +$154K |
|
|
CMCT
3135
Creative Media & Community Trust
CMCT
$10.3M
| $976K | ﹤0.01% |
4
+1
| +33% | +$246K |
|
3136
Shinhan Financial Group
SHG
$32.8B
| $974K | ﹤0.01% |
+40,493
| New | +$991K |
|
|
BBL
3137
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $974K | ﹤0.01% |
23,702
-17,985
| -43% | -$655K |
|
|
GOLD
3138
Gold.com Inc
GOLD
$1.2B
| $970K | ﹤0.01% |
101,842
+62,794
| +161% | +$496K |
|
|
FMTX
3139
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $962K | ﹤0.01% |
+20,695
| New | +$897K |
|
3140
Ardmore Shipping
ASC
$710M
| $958K | ﹤0.01% |
220,738
+8,271
| +4% | +$44.3K |
|
3141
Avalo Therapeutics
AVTX
$965M
| $957K | ﹤0.01% |
128
+36
| +39% | +$261K |
|
|
SRT
3142
DELISTED
Startek Inc.
SRT
| $955K | ﹤0.01% |
188,003
+8,024
| +4% | +$31.7K |
|
3143
Altimmune
ALT
$552M
| $953K | ﹤0.01% |
89,034
+2,859
| +3% | +$15.7K |
|
|
CKPT
3144
DELISTED
Checkpoint Therapeutics
CKPT
| $947K | ﹤0.01% |
47,832
+11,866
| +33% | +$216K |
|
3145
Biglari Holdings Class B
BH
$1.25B
| $946K | ﹤0.01% |
13,715
-113
| -0.8% | -$7.27K |
|
3146
Atlanticus Holdings
ATLC
$1.59B
| $945K | ﹤0.01% |
91,469
+34,249
| +60% | +$455K |
|
|
PAMT
3147
PAMT Corp
PAMT
$338M
| $945K | ﹤0.01% |
123,004
+260
| +0.2% | +$2.17K |
|
|
AIFU
3148
AIFU Inc
AIFU
$206M
| $943K | ﹤0.01% |
118
-2
| -2% | -$15.7K |
|
3149
Alamos Gold
AGI
$11.6B
| $935K | ﹤0.01% |
100,383
+7,548
| +8% | +$58K |
|
3150
Nature's Sunshine
NATR
$354M
| $935K | ﹤0.01% |
103,851
+6,491
| +7% | +$56.4K |
|
Similar funds
Geode Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Geode Capital Management held 4,219 positions worth $467B, up 22% from $384B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q2 2020 filing shows 118 new, 2,550 increased, 1,055 reduced and 119 closed positions. Its largest new stake was Otis Worldwide: 6,650,358 shares worth $377M. The largest sale was Allergan plc, an estimated $878M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q2 2020 buy was Otis Worldwide: 6,650,358 shares worth $377M.
- Geode Capital Management added most to Amazon in Q2 2020, an estimated $524M increase.
- Geode Capital Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $435M.
- Geode Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $878M.
- Geode Capital Management's ten largest holdings make up 23% of its $467B portfolio in Q2 2020.
- Geode Capital Management opened 118 new positions and closed 119 in Q2 2020.
- Geode Capital Management's portfolio value rose 22% quarter-over-quarter to $467B.
Based on Geode Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.